Celltrion, Inc. (KRX:068270)
South Korea · Delayed Price · Currency is KRW 190,700
-600 (-0.31%)
At close: Aug 28, 2026
Celltrion Market Cap
Celltrion has a market cap or net worth of 45.77 trillion as of August 28, 2026. Its market cap has increased by 21.64% in one year.
Market Cap
45.77T
Enterprise Value
48.52T
Revenue
4.90T
Ranking
n/a
PE Ratio
27.88
Stock Price
190,700.00
ChartMarket Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 45.77T, an increase of 43,990.88%. That is a compound annual growth rate of 40.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 45.77T | 15.57% |
| Dec 30, 2025 | 39.60T | -1.89% |
| Dec 30, 2024 | 40.37T | 44.32% |
| Dec 28, 2023 | 27.97T | 21.61% |
| Dec 29, 2022 | 23.00T | -16.64% |
| Dec 30, 2021 | 27.59T | -43.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 68.71T |
| ALTEOGEN | 22.28T |
| Samsung Epis Holdings | 9.28T |
| SK Biopharmaceuticals | 6.89T |
| HLB Co., Ltd. | 4.79T |
| Peptron | 4.49T |
| ABL Bio | 4.31T |
| LigaChem Biosciences | 3.72T |